Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

ALX ONCOLOGY ($ALXO) Releases Q4 2025 Earnings

None

ALX ONCOLOGY ($ALXO) posted quarterly earnings results for Q4 2025 on Friday, February 27th. The company reported earnings of -$0.42 per share, missing estimates of -$0.37 by $0.05. The company also reported revenue of $0, equaling estimates of $0 by $0.

You can see Quiver Quantitative's $ALXO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ALX ONCOLOGY Insider Trading Activity

ALXO Insider Trades

ALX ONCOLOGY insiders have traded $ALXO stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ALXO stock by insiders over the last 6 months:

  • COREY S GOODMAN purchased 3,184,713 shares for an estimated $4,999,999
  • JASON LETTMANN (CHIEF EXECUTIVE OFFICER) has made 2 purchases buying 92,233 shares for an estimated $99,352 and 0 sales.
  • SHELLY PINTO (SVP, FINANCE AND CAO) sold 3,925 shares for an estimated $4,356

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ALX ONCOLOGY Hedge Fund Activity

We have seen 25 institutional investors add shares of ALX ONCOLOGY stock to their portfolio, and 33 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles